Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 4.1.1.17 extracted from

  • Shantz, L.M.; Levin, V.A.
    Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential (2007), Amino Acids, 33, 213-223.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
additional information ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, overview Mus musculus
additional information ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, overview Rattus norvegicus
additional information ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, overview, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, ODC activity is induced in cells that overexpress the translation initiation factor eIF4E, overview Homo sapiens

Application

Application Comment Organism
diagnostics a single nucleotide polymorphism in intron 1 of the ODC gene serves as genetic marker for colon cancer Homo sapiens
drug development the enzyme ODC is a drug target in human malignancies, such as skin cancer Homo sapiens
pharmacology the enzyme ODC is possibly useful in chemotherapy of human malignancies, such as skin cancer Homo sapiens

Cloned(Commentary)

Cloned (Comment) Organism
expression of ODC in transgenic mice or rats leading to altered, tumoric skin phenotypes, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc, expression in NIH-3T3 cells overexpressing eIF4E, alpha-difluoromethylornithine not only inhibits proliferation, but also reverts the transformed phenotype of NIH-3T3 cells overexpressing eIF4E Homo sapiens

Protein Variants

Protein Variants Comment Organism
additional information ODC transgenic rodent models of skin carcinogenesis, phenotypes, overview Homo sapiens
additional information transgenic mice overexpressing ODC in hair follicle keratinocytes using keratin promotors are much more sensitive than littermate controls to DMBA-induced carcinogenesis, and do not require treatment with a tumor promoter to develop tumors, overview Mus musculus

General Stability

General Stability Organism
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Mus musculus
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Homo sapiens
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Rattus norvegicus

Inhibitors

Inhibitors Comment Organism Structure
alpha-difluoromethylornithine i.e. DFMO, irreversible inactivator, physiologic effects, e.g. causes arrest in G1 phase in neuroblastoma cells, the cytostatic effect is reversible by putrescine, overview, acts synergistically with SAM486A, MDL-73811, cisplatin, and 5-fluorouracil Homo sapiens
alpha-difluoromethylornithine i.e. DFMO, irreversible inactivator, antitumor action of ODC inhibition using DFMO, chemopreventive effects, DFMO provides significant protection against N-butyl-N(4-hydroxybutyl)-nitrosamine-induced bladder cancer, overview Mus musculus
alpha-difluoromethylornithine i.e. DFMO, irreversible inactivator, antitumor action of ODC inhibition using DFMO, chemopreventive effects, DFMO provides significant protection against 7,12-dimethylbenz[a]-anthracene-induced mammary carcinogenesis, overview Rattus norvegicus
antizyme an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Homo sapiens
antizyme an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Mus musculus
antizyme an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Rattus norvegicus
additional information the enzyme is induced by phorbol esters, rapamycin, which blocks phosphorylation of 4E-BP1, inhibits the induction of ODC in response to serum Homo sapiens
additional information inhibition of ODC activity reverts the transformation of cells in vitro and reduces tumor growth Mus musculus
additional information inhibition of ODC activity reverts the transformation of cells in vitro and reduces tumor growth Rattus norvegicus

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
L-ornithine Rattus norvegicus first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview putrescine + CO2
-
?
L-ornithine Homo sapiens first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms, e.g. via the Ras effector pathways, and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects, overview putrescine + CO2
-
?
L-ornithine Mus musculus first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview putrescine + CO2
-
?
additional information Mus musculus the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview ?
-
?
additional information Rattus norvegicus the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview ?
-
?
additional information Homo sapiens the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, the Raf/MEK/ERK cascade mediates ODC transcription and the PI 3-kinase cascade mediates ODC translation, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc ?
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-
Mus musculus
-
MEK mutant K14-MEK mice
-
Rattus norvegicus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
AR4-2J cell AR4-2J pancreatic tumor cells, which show increased phosphorylation of the eIF4E regulatory protein 4E-BP1 and high levels of eIF4E compared to normal cells, also exhibit increased translational initiation of ODC mRNA Rattus norvegicus
-
B-16 cell melanoma cell line Mus musculus
-
COLO-357 cell
-
Homo sapiens
-
hepatoma cell
-
Homo sapiens
-
hepatoma cell
-
Rattus norvegicus
-
IEC-6 cell intestinal epithelial cells Rattus norvegicus
-
intestine
-
Rattus norvegicus
-
L-1210 cell leukemia cell line Mus musculus
-
LAN-1 cell neuroblastoma cell line Homo sapiens
-
Lewis lung carcinoma cell
-
Mus musculus
-
melanoma cell
-
Homo sapiens
-
neuroblastoma cell
-
Homo sapiens
-
NMB-7 cell neuroblastoma cell line Homo sapiens
-
PANC-1 cell
-
Homo sapiens
-
pancreas
-
Homo sapiens
-
pancreatic cancer cell
-
Homo sapiens
-
renal cell carcinoma cell
-
Homo sapiens
-
skin
-
Mus musculus
-
skin
-
Homo sapiens
-
skin
-
Rattus norvegicus
-
small cell lung carcinoma cell
-
Mus musculus
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
L-ornithine
-
Mus musculus putrescine + CO2
-
?
L-ornithine
-
Homo sapiens putrescine + CO2
-
?
L-ornithine
-
Rattus norvegicus putrescine + CO2
-
?
L-ornithine first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview Rattus norvegicus putrescine + CO2
-
?
L-ornithine first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms, e.g. via the Ras effector pathways, and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects, overview Homo sapiens putrescine + CO2
-
?
L-ornithine first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview Mus musculus putrescine + CO2
-
?
additional information the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview Mus musculus ?
-
?
additional information the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview Rattus norvegicus ?
-
?
additional information the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, the Raf/MEK/ERK cascade mediates ODC transcription and the PI 3-kinase cascade mediates ODC translation, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc Homo sapiens ?
-
?

Subunits

Subunits Comment Organism
dimer antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Mus musculus
dimer antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Homo sapiens
dimer antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation Rattus norvegicus

Synonyms

Synonyms Comment Organism
ODC
-
Mus musculus
ODC
-
Homo sapiens
ODC
-
Rattus norvegicus

Cofactor

Cofactor Comment Organism Structure
pyridoxal 5'-phosphate
-
Mus musculus
pyridoxal 5'-phosphate
-
Homo sapiens
pyridoxal 5'-phosphate
-
Rattus norvegicus